Some people who cannot tolerate tirzepatide GI effects do fine on semaglutide, and vice versa
When both conditions occur together, the risk of heart disease, stroke, kidney disorders, and certain cancers increases
This triple mechanism of action distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist)
Severe nausea makes eating difficult, which may lead to nutritional deficiencies and metabolism slowdownthe opposite of desired outcomes
Bariatric Surgery: A Proven Long-Term Solution Bariatric surgery is a well-researched and highly effective treatment for severe obesity
While these recommendations are based on observations of thyroid C-cell tumors in rats, it is still unknown whether tirzepatide may also cause thyroid tumors, including medullary thyroid carcinoma, in humans